Predicted modeling in cancer: Where systems biology meets the stock market

Expert Review of Anticancer Therapy

Volumn 9, Issue 7, 2009, Pages 867-870

  Abbod, Maysam F ^a   Hamdy, Freddie C ^b   Linkens, Derek A ^c   Catto, James W F ^d  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL INTELLIGENCE; ARTIFICIAL NEURAL NETWORK; BAYES THEOREM; BLADDER CANCER; COMPUTER MODEL; COMPUTER PREDICTION; DECISION SUPPORT SYSTEM; EDITORIAL; ENVIRONMENTAL FACTOR; EXPERT SYSTEM; FUZZY SYSTEM; IMAGE PROCESSING; PATIENT CARE; PREDICTION; PREDICTION AND FORECASTING; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS; SYSTEMS BIOLOGY; TREATMENT PLANNING; FORECASTING; FUZZY LOGIC; HUMAN; NEOPLASM; PROGNOSIS; STATISTICAL MODEL;

ARTIFICIAL INTELLIGENCE; FORECASTING; FUZZY LOGIC; HUMANS; MODELS, STATISTICAL; NEOPLASMS; PROGNOSIS;

EID: 69249134652     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.09.47     Document Type: Editorial

References (20)

1. Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 21(18), 1315-1330 (2003).
2. Shariat SF, Margulis V, Lotan Y, Montorsi F, Karakiewicz PI. Nomograms for bladder cancer. Eur. Urol. 54(1), 41-53 (2008).
3. Rouzier R, Pusztai L, Delaloge S et al. Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer. J. Clin. Oncol. 23(33), 8331-8339 (2005).
4. Weiser MR, Landmann RG, Kattan MW et al. Individualized prediction of colon cancer recurrence using a nomogram. J. Clin. Oncol. 26(3), 380-385 (2008).
5. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World]. Urol. 21(6), 392-401 (2004).
6. Catto JW, Linkens DA, Abbod MF et al. Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks. Clin. Cancer Res. 9(11), 4172-4177 (2003).
7. Lotan Y, Capitanio U, Shariat SF, Hutterer GC, Karakiewicz PI. Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection. BJU Int. 103(10), 1368-1374 (2009).
8. Shariat SF, Karakiewicz PI, Margulis V, Kattan MW. Inventory of prostate cancer predictive tools. Curr. Opin. Urol. 18(3), 279-296 (2008).
9. Bochner BH, Kattan MW, Vora KC. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J. Clin. Oncol. 24(24), 3967-3972 (2006).
10. Shariat SF, Karakiewicz PI, Palapattu GS et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin. Cancer Res. 12(22), 6663-6676 (2006).
11. Abbod MF, Catto JW, Linkens DA, Hamdy FC. Application of artificial intelligence to the management of urological cancer. J. Urol. 178(4), 1150-1156 (2007).
12. Schwarzer G, Vach W, Schumacher M. On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology. Stat. Med. 19(4), 541-561 (2000).
13. Sargent DJ. Comparison of artificial neural networks with other statistical approaches: results from medical data sets. Cancer 91(8 Suppl.), 1636-1642 (2001).
14. Lisboa PJ, Taktak AF. The use of artificial neural networks in decision support in cancer: a systematic review. Neural Netw. 19(4), 408-415 (2006).
15. Chen M, Linkens DA. A systematic neurofuzzy modelling framework with application to material property prediction. EEE Trans. Syst. Man. Cybern. B Cybern. 31(5), 781 (2001).
16. Catto JW, Abbod MF, Linkens DA, Hamdy FC. Neuro-fuzzy modeling: an accurate and interpretable method for predicting bladder cancer progression. J. Urol. 175(2), 474-479 (2006).
17. Yates DR, Rehman I, Abbod MF et al. Promoter hypermethylation identifies progression risk in bladder cancer. Clin. Cancer Res. 13(7), 2046-2053 (2007).
18. Catto JW, Abbod MF, Linkens DA, Larre S, Rosario DJ, Hamdy FC. Neurofuzzy modeling to determine recurrence risk following radical cystectomy for non-metastatic urothelial carcinoma of the bladder. Clin. Cancer Res. 15, 3150 (2009).
19. Khan J, Wei JS, Ringner M et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat. Med. 7(6), 673-679 (2001).
20. Lancashire LJ, Powe DG, Reis-Filho JS et al. "" A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks. Breast Cancer Res. Treat. DOI: 10.1007/s10549-009-0378-1 (2009).